Quanterix price target lowered to $28 from $32 at Scotiabank

Scotiabank lowered the firm’s price target on Quanterix to $28 from $32 and keeps an Outperform rating on the shares. The company’s Q2 results beat expectations, but FY24 revenue guidance was reduced due to continued challenges in the capital equipment spending environment and potential related impact on consumables pull-through for 2H of 2024, the analyst tells investors.